Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,390
Closed -$629K 400
2025
Q2
$629K Hold
6,390
﹤0.01% 265
2025
Q1
$592K Hold
6,390
﹤0.01% 280
2024
Q4
$580K Hold
6,390
﹤0.01% 275
2024
Q3
$617K Hold
6,390
﹤0.01% 252
2024
Q2
$587K Hold
6,390
0.01% 254
2024
Q1
$589K Sell
6,390
-3,000
-32% -$281K 0.01% 265
2023
Q4
$893K Hold
9,390
0.01% 246
2023
Q3
$877K Hold
9,390
0.01% 288
2023
Q2
$859K Sell
9,390
-505
-5% -$41.4K 0.01% 347
2023
Q1
$728K Sell
9,895
-665
-6% -$57.5K 0.01% 418
2022
Q4
$882K Sell
10,560
-43,603
-81% -$3.93M 0.01% 417
2022
Q3
$5.24M Sell
54,163
-38,205
-41% -$4.56M 0.06% 176
2022
Q2
$9.71K Sell
92,368
-11,461
-11% -$1.46M 0.1% 100
2022
Q1
$17.9M Buy
103,829
+35,525
+52% +$5.31M 0.14% 85
2021
Q4
$11.1M Buy
68,304
+31,621
+86% +$5.08M 0.08% 123
2021
Q3
$5.47M Buy
36,683
+19,904
+119% +$4.14M 0.06% 144
2021
Q2
$4.11M Buy
+16,779
New +$4.4M 0.05% 162

Other funds holding AMED

Banque Pictet & Cie's AMED Position: Q3 2025 in Review

Banque Pictet & Cie sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,390 shares — an estimated $629K sold.

Banque Pictet & Cie first reported a position in AMED in Q2 2021 and held it in 17 quarters. The position peaked at $17.9M in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Banque Pictet & Cie reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Banque Pictet & Cie sold 6,390 Amedisys shares in Q3 2025, an estimated $629K.
  • Banque Pictet & Cie first reported a position in Amedisys in Q2 2021 and held it in 17 quarters.
  • Banque Pictet & Cie's Amedisys position peaked at $17.9M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Banque Pictet & Cie's 13F filing for Q3 2025, filed 21 Oct 2025.